Institute of Chemical Technology (ICT), Mumbai has received a prestigious grant from Bill & Melinda Gates Foundation to develop the first green nanovaccine for nasal immunization against brucellosis. Prof. Vandana Patravale, ICT, Matunga was awarded USD100,000 in phase I of Grand Challenges Explorations Round 11 for developing the cost-effective vaccine technology from over 2700 applications. The sub-unit nanovaccine aims to confer long term protective immunity to humans and livestock population. Currently, Brucellosis is a zoonotic bacterial infection with a potential to be exploited as a bioweapon, and currently no human vaccine is available for treatment
Roselabs Bioscience Ltd and Roselabs Polymers Ltd is planning to invest Rs. 4000 million to manufacture pre-filled syringes in India. The method of using pre-filled syringe is designed to provide assured sterility, safety, convenience, greater accuracy, minimal over-filling, least medical waste, freedom from needle phobia and least chances of accidental needle stick injuries. The company has the capacity to manufacture 8 lakh syringes daily. Currently, 95% of pre-filled syringes are imported.Latest News :
The company is in the process of raising Rs. 1000 million towards private equity placements and venture capital
CKS Pharma Labs Pvt Ltd to set up a bulk drug unit in Jaggayapet in Krishna district of Andhra Pradesh with an investment of Rs. 42 million. The project involves setting up of a bulk drug unit to produce Pantoprazole Sodium, Carvedilol, Lansoprazole,Prasugrel Hydrochloride, LevoCetrizine Dihydrochloride, Lamotrigine, Lamivudine, Fluconazole etc., and will have a total capacity of 15.20 mtpm.